Discussion about this post

User's avatar
Ethical Skeptic ☀'s avatar

Thanks for this Galileo,

I extracted the severe entries from the data, which mostly pertained for the short-term, to neurological events (Bell's Palsy, Memory or Hearing Loss, etc.), since myocarditis is often diagnosed much later than the window of the study. I then compared that 'severe' group to the severe events reported in the US VAERS database, extracted 5 Feb 2022.

If this is comparative, and I am sure that I am under-estimating this by several shortfalls in specific AE's (death, myocarditis, stroke, etc.), then the US VAERS database is under-reporting severe adverse events, by a factor of 30 to 1 on these AE's alone.

EVG

TES :-)

Expand full comment
Hannah W's avatar

This is surreal -- I just tried to find a mention of this report on the wider Internet... ANYWHERE... and not a peep. It's only circulating in Hebrew media.

Even Israel Hayom, which reported this in detail on the 9th (before it was released to the public?) didn't bother posting a story to their English site.

You are apparently 'scooping' them all. Kol HaKAVOD!

Expand full comment
26 more comments...

No posts